Selected research
Market Analysis & Forecast
Global Lafutidine Tablets Market Analysis and Forecast 2026-2032
Market perspective
The global Lafutidine Tablets market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Lafutidine Tablets is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Europe market for Lafutidine Tablets is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Read the full market overview
Asia-Pacific market for Lafutidine Tablets is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The China market for Lafutidine Tablets is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The major global manufacturers of Lafutidine Tablets include Yuekang Pharmaceutical Group Co., Ltd., Sichuan Kelun Pharmaceutical Co., Ltd., Shandong Qidu Pharmaceutical Co., Ltd., Jiangsu Runbang Pharmaceutical Co., Ltd., China Resources Double Crane Pharmaceutical Co., Ltd., Hubei Shubang Pharmaceutical Co., Ltd. and Chengdu Hengrui Pharmaceutical Co., Ltd., etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Lafutidine Tablets, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of Lafutidine Tablets, also provides the sales of main regions and countries. Of the upcoming market potential for Lafutidine Tablets, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Lafutidine Tablets sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Lafutidine Tablets market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Lafutidine Tablets sales, projected growth trends, production technology, application and end-user industry.
Lafutidine Tablets Segment by Company
Yuekang Pharmaceutical Group Co., Ltd.
Sichuan Kelun Pharmaceutical Co., Ltd.
Shandong Qidu Pharmaceutical Co., Ltd.
Jiangsu Runbang Pharmaceutical Co., Ltd.
China Resources Double Crane Pharmaceutical Co., Ltd.
Hubei Shubang Pharmaceutical Co., Ltd.
Chengdu Hengrui Pharmaceutical Co., Ltd.
Lafutidine Tablets Segment by Type
10mg
5mg
Lafutidine Tablets Segment by Application
Hospital
Clinic
Other
Lafutidine Tablets Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Lafutidine Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Lafutidine Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Lafutidine Tablets.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of Lafutidine Tablets in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Lafutidine Tablets manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Lafutidine Tablets sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 10mg
- 5mg
Applications
- Hospital
- Clinic
- Other
Companies covered
- Yuekang Pharmaceutical Group Co., Ltd.
- Sichuan Kelun Pharmaceutical Co., Ltd.
- Shandong Qidu Pharmaceutical Co., Ltd.
- Jiangsu Runbang Pharmaceutical Co., Ltd.
- China Resources Double Crane Pharmaceutical Co., Ltd.
- Hubei Shubang Pharmaceutical Co., Ltd.
- Chengdu Hengrui Pharmaceutical Co., Ltd.
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Lafutidine Tablets Market by Type
- 1.2.1 Global Lafutidine Tablets Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 10mg
- 1.2.3 5mg
- 1.3 Lafutidine Tablets Market by Application
- 1.3.1 Global Lafutidine Tablets Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 Hospital
- 1.3.3 Clinic
- 1.3.4 Other
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Lafutidine Tablets Market Dynamics
- 2.1 Lafutidine Tablets Industry Trends
- 2.2 Lafutidine Tablets Industry Drivers
- 2.3 Lafutidine Tablets Industry Opportunities and Challenges
- 2.4 Lafutidine Tablets Industry Restraints
3 Global Market Growth Prospects
- 3.1 Global Lafutidine Tablets Revenue Estimates and Forecasts (2021-2032)
- 3.2 Global Lafutidine Tablets Revenue by Region
- 3.2.1 Global Lafutidine Tablets Revenue by Region: 2021 VS 2025 VS 2032
- 3.2.2 Global Lafutidine Tablets Revenue by Region (2021-2026)
- 3.2.3 Global Lafutidine Tablets Revenue by Region (2027-2032)
- 3.2.4 Global Lafutidine Tablets Revenue Market Share by Region (2021-2032)
- 3.3 Global Lafutidine Tablets Sales Estimates and Forecasts 2021-2032
- 3.4 Global Lafutidine Tablets Sales by Region
- 3.4.1 Global Lafutidine Tablets Sales by Region: 2021 VS 2025 VS 2032
- 3.4.2 Global Lafutidine Tablets Sales by Region (2021-2026)
- 3.4.3 Global Lafutidine Tablets Sales by Region (2027-2032)
- 3.4.4 Global Lafutidine Tablets Sales Market Share by Region (2021-2032)
- 3.5 US & Canada & Mexico
- 3.6 Europe
- 3.7 China
- 3.8 Asia (Excluding China)
- 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
- 4.1 Global Lafutidine Tablets Revenue by Manufacturers
- 4.1.1 Global Lafutidine Tablets Revenue by Manufacturers (2021-2026)
- 4.1.2 Global Lafutidine Tablets Revenue Market Share by Manufacturers (2021-2026)
- 4.1.3 Global Lafutidine Tablets Manufacturers Revenue Share Top 10 and Top 5 in 2025
- 4.2 Global Lafutidine Tablets Sales by Manufacturers
- 4.2.1 Global Lafutidine Tablets Sales by Manufacturers (2021-2026)
- 4.2.2 Global Lafutidine Tablets Sales Market Share by Manufacturers (2021-2026)
- 4.2.3 Global Lafutidine Tablets Manufacturers Sales Share Top 10 and Top 5 in 2025
- 4.3 Global Lafutidine Tablets Sales Price by Manufacturers (2021-2026)
- 4.4 Global Lafutidine Tablets Key Manufacturers Ranking, 2024 VS 2025 VS 2026
- 4.5 Global Lafutidine Tablets Key Manufacturers Manufacturing Sites & Headquarters
- 4.6 Global Lafutidine Tablets Manufacturers, Product Type & Application
- 4.7 Global Lafutidine Tablets Manufacturers' Establishment Date
- 4.8 Market Competitive Analysis
- 4.8.1 Global Lafutidine Tablets Market CR5 and HHI
- 4.8.2 2025 Lafutidine Tablets Tier 1, Tier 2, and Tier 3
5 Lafutidine Tablets Market by Type
- 5.1 Global Lafutidine Tablets Revenue by Type
- 5.1.1 Global Lafutidine Tablets Revenue by Type (2021 VS 2025 VS 2032)
- 5.1.2 Global Lafutidine Tablets Revenue by Type (2021-2032) & (US$ Million)
- 5.1.3 Global Lafutidine Tablets Revenue Market Share by Type (2021-2032)
- 5.2 Global Lafutidine Tablets Sales by Type
- 5.2.1 Global Lafutidine Tablets Sales by Type (2021 VS 2025 VS 2032)
- 5.2.2 Global Lafutidine Tablets Sales by Type (2021-2032) & (K Units)
- 5.2.3 Global Lafutidine Tablets Sales Market Share by Type (2021-2032)
- 5.3 Global Lafutidine Tablets Price by Type
6 Lafutidine Tablets Market by Application
- 6.1 Global Lafutidine Tablets Revenue by Application
- 6.1.1 Global Lafutidine Tablets Revenue by Application (2021 VS 2025 VS 2032)
- 6.1.2 Global Lafutidine Tablets Revenue by Application (2021-2032) & (US$ Million)
- 6.1.3 Global Lafutidine Tablets Revenue Market Share by Application (2021-2032)
- 6.2 Global Lafutidine Tablets Sales by Application
- 6.2.1 Global Lafutidine Tablets Sales by Application (2021 VS 2025 VS 2032)
- 6.2.2 Global Lafutidine Tablets Sales by Application (2021-2032) & (K Units)
- 6.2.3 Global Lafutidine Tablets Sales Market Share by Application (2021-2032)
- 6.3 Global Lafutidine Tablets Price by Application
7 Company Profiles
- 7.1 Yuekang Pharmaceutical Group Co., Ltd.
- 7.1.1 Yuekang Pharmaceutical Group Co., Ltd. Company Information
- 7.1.2 Yuekang Pharmaceutical Group Co., Ltd. Business Overview
- 7.1.3 Yuekang Pharmaceutical Group Co., Ltd. Lafutidine Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.1.4 Yuekang Pharmaceutical Group Co., Ltd. Lafutidine Tablets Product Portfolio
- 7.1.5 Yuekang Pharmaceutical Group Co., Ltd. Recent Developments
- 7.2 Sichuan Kelun Pharmaceutical Co., Ltd.
- 7.2.1 Sichuan Kelun Pharmaceutical Co., Ltd. Company Information
- 7.2.2 Sichuan Kelun Pharmaceutical Co., Ltd. Business Overview
- 7.2.3 Sichuan Kelun Pharmaceutical Co., Ltd. Lafutidine Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.2.4 Sichuan Kelun Pharmaceutical Co., Ltd. Lafutidine Tablets Product Portfolio
- 7.2.5 Sichuan Kelun Pharmaceutical Co., Ltd. Recent Developments
- 7.3 Shandong Qidu Pharmaceutical Co., Ltd.
- 7.3.1 Shandong Qidu Pharmaceutical Co., Ltd. Company Information
- 7.3.2 Shandong Qidu Pharmaceutical Co., Ltd. Business Overview
- 7.3.3 Shandong Qidu Pharmaceutical Co., Ltd. Lafutidine Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.3.4 Shandong Qidu Pharmaceutical Co., Ltd. Lafutidine Tablets Product Portfolio
- 7.3.5 Shandong Qidu Pharmaceutical Co., Ltd. Recent Developments
- 7.4 Jiangsu Runbang Pharmaceutical Co., Ltd.
- 7.4.1 Jiangsu Runbang Pharmaceutical Co., Ltd. Company Information
- 7.4.2 Jiangsu Runbang Pharmaceutical Co., Ltd. Business Overview
- 7.4.3 Jiangsu Runbang Pharmaceutical Co., Ltd. Lafutidine Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.4.4 Jiangsu Runbang Pharmaceutical Co., Ltd. Lafutidine Tablets Product Portfolio
- 7.4.5 Jiangsu Runbang Pharmaceutical Co., Ltd. Recent Developments
- 7.5 China Resources Double Crane Pharmaceutical Co., Ltd.
- 7.5.1 China Resources Double Crane Pharmaceutical Co., Ltd. Company Information
- 7.5.2 China Resources Double Crane Pharmaceutical Co., Ltd. Business Overview
- 7.5.3 China Resources Double Crane Pharmaceutical Co., Ltd. Lafutidine Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.5.4 China Resources Double Crane Pharmaceutical Co., Ltd. Lafutidine Tablets Product Portfolio
- 7.5.5 China Resources Double Crane Pharmaceutical Co., Ltd. Recent Developments
- 7.6 Hubei Shubang Pharmaceutical Co., Ltd.
- 7.6.1 Hubei Shubang Pharmaceutical Co., Ltd. Company Information
- 7.6.2 Hubei Shubang Pharmaceutical Co., Ltd. Business Overview
- 7.6.3 Hubei Shubang Pharmaceutical Co., Ltd. Lafutidine Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.6.4 Hubei Shubang Pharmaceutical Co., Ltd. Lafutidine Tablets Product Portfolio
- 7.6.5 Hubei Shubang Pharmaceutical Co., Ltd. Recent Developments
- 7.7 Chengdu Hengrui Pharmaceutical Co., Ltd.
- 7.7.1 Chengdu Hengrui Pharmaceutical Co., Ltd. Company Information
- 7.7.2 Chengdu Hengrui Pharmaceutical Co., Ltd. Business Overview
- 7.7.3 Chengdu Hengrui Pharmaceutical Co., Ltd. Lafutidine Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.7.4 Chengdu Hengrui Pharmaceutical Co., Ltd. Lafutidine Tablets Product Portfolio
- 7.7.5 Chengdu Hengrui Pharmaceutical Co., Ltd. Recent Developments
8 North America
- 8.1 North America Lafutidine Tablets Market Size by Type
- 8.1.1 North America Lafutidine Tablets Revenue by Type (2021-2032)
- 8.1.2 North America Lafutidine Tablets Sales by Type (2021-2032)
- 8.1.3 North America Lafutidine Tablets Price by Type (2021-2032)
- 8.2 North America Lafutidine Tablets Market Size by Application
- 8.2.1 North America Lafutidine Tablets Revenue by Application (2021-2032)
- 8.2.2 North America Lafutidine Tablets Sales by Application (2021-2032)
- 8.2.3 North America Lafutidine Tablets Price by Application (2021-2032)
- 8.3 North America Lafutidine Tablets Market Size by Country
- 8.3.1 North America Lafutidine Tablets Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 8.3.2 North America Lafutidine Tablets Sales by Country (2021 VS 2025 VS 2032)
- 8.3.3 North America Lafutidine Tablets Price by Country (2021-2032)
- 8.3.4 United States
- 8.3.5 Canada
- 8.3.6 Mexico
9 Europe
- 9.1 Europe Lafutidine Tablets Market Size by Type
- 9.1.1 Europe Lafutidine Tablets Revenue by Type (2021-2032)
- 9.1.2 Europe Lafutidine Tablets Sales by Type (2021-2032)
- 9.1.3 Europe Lafutidine Tablets Price by Type (2021-2032)
- 9.2 Europe Lafutidine Tablets Market Size by Application
- 9.2.1 Europe Lafutidine Tablets Revenue by Application (2021-2032)
- 9.2.2 Europe Lafutidine Tablets Sales by Application (2021-2032)
- 9.2.3 Europe Lafutidine Tablets Price by Application (2021-2032)
- 9.3 Europe Lafutidine Tablets Market Size by Country
- 9.3.1 Europe Lafutidine Tablets Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 9.3.2 Europe Lafutidine Tablets Sales by Country (2021 VS 2025 VS 2032)
- 9.3.3 Europe Lafutidine Tablets Price by Country (2021-2032)
- 9.3.4 Germany
- 9.3.5 France
- 9.3.6 U.K.
- 9.3.7 Italy
- 9.3.8 Russia
- 9.3.9 Spain
- 9.3.10 Netherlands
10 China
- 10.1 China Lafutidine Tablets Market Size by Type
- 10.1.1 China Lafutidine Tablets Revenue by Type (2021-2032)
- 10.1.2 China Lafutidine Tablets Sales by Type (2021-2032)
- 10.1.3 China Lafutidine Tablets Price by Type (2021-2032)
- 10.2 China Lafutidine Tablets Market Size by Application
- 10.2.1 China Lafutidine Tablets Revenue by Application (2021-2032)
- 10.2.2 China Lafutidine Tablets Sales by Application (2021-2032)
- 10.2.3 China Lafutidine Tablets Price by Application (2021-2032)
11 Asia (Excluding China)
- 11.1 Asia Lafutidine Tablets Market Size by Type
- 11.1.1 Asia Lafutidine Tablets Revenue by Type (2021-2032)
- 11.1.2 Asia Lafutidine Tablets Sales by Type (2021-2032)
- 11.1.3 Asia Lafutidine Tablets Price by Type (2021-2032)
- 11.2 Asia Lafutidine Tablets Market Size by Application
- 11.2.1 Asia Lafutidine Tablets Revenue by Application (2021-2032)
- 11.2.2 Asia Lafutidine Tablets Sales by Application (2021-2032)
- 11.2.3 Asia Lafutidine Tablets Price by Application (2021-2032)
- 11.3 Asia Lafutidine Tablets Market Size by Country
- 11.3.1 Asia Lafutidine Tablets Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 11.3.2 Asia Lafutidine Tablets Sales by Country (2021 VS 2025 VS 2032)
- 11.3.3 Asia Lafutidine Tablets Price by Country (2021-2032)
- 11.3.4 Japan
- 11.3.5 South Korea
- 11.3.6 India
- 11.3.7 Australia
- 11.3.8 Taiwan
- 11.3.9 Southeast Asia
12 South America, Middle East and Africa
- 12.1 SAMEA Lafutidine Tablets Market Size by Type
- 12.1.1 SAMEA Lafutidine Tablets Revenue by Type (2021-2032)
- 12.1.2 SAMEA Lafutidine Tablets Sales by Type (2021-2032)
- 12.1.3 SAMEA Lafutidine Tablets Price by Type (2021-2032)
- 12.2 SAMEA Lafutidine Tablets Market Size by Application
- 12.2.1 SAMEA Lafutidine Tablets Revenue by Application (2021-2032)
- 12.2.2 SAMEA Lafutidine Tablets Sales by Application (2021-2032)
- 12.2.3 SAMEA Lafutidine Tablets Price by Application (2021-2032)
- 12.3 SAMEA Lafutidine Tablets Market Size by Country
- 12.3.1 SAMEA Lafutidine Tablets Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 12.3.2 SAMEA Lafutidine Tablets Sales by Country (2021 VS 2025 VS 2032)
- 12.3.3 SAMEA Lafutidine Tablets Price by Country (2021-2032)
- 12.3.4 Brazil
- 12.3.5 Argentina
- 12.3.6 Chile
- 12.3.7 Colombia
- 12.3.8 Peru
- 12.3.9 Saudi Arabia
- 12.3.10 Israel
- 12.3.11 UAE
- 12.3.12 Turkey
- 12.3.13 Iran
- 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
- 13.1 Lafutidine Tablets Value Chain Analysis
- 13.1.1 Lafutidine Tablets Key Raw Materials
- 13.1.2 Raw Materials Key Suppliers
- 13.1.3 Manufacturing Cost Structure
- 13.1.4 Lafutidine Tablets Production Mode & Process
- 13.2 Lafutidine Tablets Sales Channels Analysis
- 13.2.1 Direct Comparison with Distribution Share
- 13.2.2 Lafutidine Tablets Distributors
- 13.2.3 Lafutidine Tablets Customers
14 Concluding Insights
15 Appendix
- 15.1 Reasons for Doing This Study
- 15.2 Research Methodology
- 15.3 Research Process
- 15.4 Authors List of This Report
- 15.5 Data Source
- 15.5.1 Secondary Sources
- 15.5.2 Primary Sources
- 15.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst